Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMGJYZ8)

Drug Name	EDP-305 DMGJYZ8
Drug Type	Small molecular drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Non-alcoholic steatohepatitis	DIST4788	DB92.1	Phase 2	[1]
Primary biliary cholangitis	DIS43E0O	DB96.1	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04378010) A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT03394924) A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis. U.S. National Institutes of Health.